Results

Generation and Characterization of Transgenic
). mice with a null mutation in dynein die in utero (Harada et al., 1998).
Mice Overexpressing Dynamitin Display Evidence To determine the onset of transgene expression, a of Motor Neuron Degeneration and Skeletal time course study was performed. M21 pups were sacri-
Muscle Atrophy
The onset of disease in transgenic mice from the M21 ficed at postnatal days 1, 3, 5, 7, 9, 11, 13, and 21, and brain homogenates were prepared. Western blots of the line begins between 5 and 9 months of age ( Figure 3A) . The severity and progression of the symptoms is varihomogenates were then probed with antibodies to the FLAG tag. Expression of the transgene in the M21 line able between littermates, but most M21 mice display hind end weakness, spontaneous and sometimes spaswas not observed until postnatal day 13 ( Figure 1C) , suggesting that abnormalities seen in these transgenic tic tremors, decreased grooming, weight loss, decreased fertility, and abnormal gaits. Mice also lose the mice are due to the effects of disrupted dynein function on mature neurons, rather than from disruptive effects ability to extend their hind legs when suspended by the base of their tail. A less severe phenotype with similar during motor neuron development. Histological analysis of the transgenic mice, which revealed no gross pertursymptoms of hind end weakness, abnormal gaits, and trembling is observed in the lower expressing M5 and bations or abnormalities in the anatomy or organization of the nervous system, also supports this conclusion.
M13 mouse lines. These milder signs do not develop until 14-18 months of age. Western blots of all major tissue types from M21 mice and age-matched controls were examined to analyze Many transgenic mice of the M21 line exhibit abnormal gaits. Some mice appear to be lame on a limb, or their the tissue specificity of transgene expression. Dynactin is enriched in nervous and muscle tissue; therefore, enposture is slumped in the hind end. A small number of transgenic mice become weak in their epaxial muscles dogenous expression of dynamitin is observed in these tissues (Melloni et al., 1995) . In skeletal muscle, there and develop a lordodic posture with an upright tail. Transgenic mice develop abnormal, slower gaits with is no significant difference in the levels of dynamitin expression between transgenic and control mice (data decreased stride lengths, which can be demonstrated by ink tests (see Figure 3C ). Mice with signs of weakness not shown). Transgenic mice display the highest expression of dynamitin in neuronal tissues, particularly the also had decreased fertility. Males did not become sick enough to prevent them from fertilizing females until spinal cord and hindbrain, as compared to control mice ( Figure 1D ). No significant differences in dynamitin exthey reached the severe stages of the disease. Females, on the other hand, were not able to successfully raise pression between transgenic and wild-type mice were observed in any tissue examined other than those from litters once they began to show signs of disease. Transgenic mice become weak and have difficulty the nervous system (data not shown). This pattern of Homogenates of spinal cord preparations from 5-month-old wild-type and transgenic mice were sedimented on 5%-20% sucrose gradients. Fractions were resolved by SDS-PAGE, and Western blot was performed using antibodies specific for the dynactin subunits p150
Glued , p62, dynamitin, Arp1, and p22 as well as antibodies to the FLAG tag and to tubulin and actin. Standards were run in parallel to determine relative densities of fractions. HSS is pre-load high-speed supernatant from mouse spinal cord homogenates. Disruption of the dynactin multiprotein complex is demonstrated by the shift of subunits into lower density fractions. p150
Glued , dynamitin, and p22 divide into a subcomplex that sediments at ‫4ف‬S while Arp1 and p62 shift one fraction from 4 to 5.
climbing on wire mesh, are not as active in the cage, and presymptomatic transgenic and wild-type male mice, 10-to 14-month-old early symptomatic transgenic and display decreased rearing activity. In order to assess the weakness that develops in dynamitin-overexpressing wild-type male mice, and Ͼ17-month-old late symptomatic transgenic and wild-type male mice. This protocol mice, analysis of 4-to 7-month-old presymptomatic transgenic and wild-type male mice, 10-to 14-monthwas designed to test the endurance of the animal rather than the maximum speed that it could run. Early sympold early symptomatic transgenic and wild-type male mice, and Ͼ17-month-old late symptomatic transgenic tomatic transgenic mice tire on average 44 min earlier than wild-type mice in the same age group (p Ͻ 0.02) and wild-type male mice by grip strength meter ( 5H, and 5N ). atic and early symptomatic mice, no loss of motor neuNeuronal processes are swollen with neurofilaments, rons nor inclusions in cell bodies or processes were and spheroids, similar to those seen with H&E, stain for observed, and only very minor, subtle histological neurofilaments ( Figure 5Q ). The neurofilament antibody changes such as swollen axons were seen in early sympused recognizes only phosphorylated heavy and light tomatic mice. Histological changes were evident in Ͼ17-subunits, so as expected, neurofilament staining was month-old late symptomatic transgenic mice when comnot observed in the cell bodies of motor neurons. Periphpared to wild-type mice in the same age group ( To determine the effects of dynamitin overexpression mice ( Figures 4C and 4D) . Widespread evidence of deon axonal numbers and caliber, L5 ventral roots of 4-nervation atrophy and regeneration is seen, but is most to 7-month-old presymptomatic transgenic and wildpronounced in the large hind limb flexors such as the type mice, 10-to 14-month-old early symptomatic and biceps femoris. Obvious histological changes such as wild-type mice, and Ͼ16-month-old late symptomatic small angular fibers ( Figure 4D, black arrows) indicating and wild-type mice were examined by light and electron denervation, centrally placed nuclei ( Figure 4D , arrowmicroscopy. Ventral roots are comprised primarily of heads), and hypertrophic fibers ( Figure 4D, asterisk) myelinated axons originating from motor neurons and were observed. Changes in muscle fibers are seen in are an accurate reflection of their numbers. Four-to small groups, suggesting that previous events of denerseven-month-old presymptomatic transgenic mice have vation and reinnervation by neighboring motor neurons 100% Ϯ 5% of the total number of axons observed in have occurred ( Figure 4D, white arrow) .
wild-type mice of the same age group. Ten-to fourteenInitial screening for dynamitin expression and evimonth-old early symptomatic transgenic mice have dence of disrupted transport in early symptomatic trans-92% Ϯ 4% of the total number of axons found in wildgenic mice at the onset of phenotype compared to agetype mice in the same age group. A decrease of 25% Ϯ matched controls was done by immunohistochemistry 6% was found in the average total number of axons using antibodies to dynamitin, neurofilaments, and syncounted in the Ͼ16-month-old late symptomatic transaptophysin. Ten-to fourteen-month-old early symptomgenic mice when compared to wild-type mice of the atic transgenic and wild-type mice were examined. Secsame age group (t test, p Ͻ 0.08). tions of fore-, mid-, and hindbrain as well as cervical,
We then counted the number of small caliber (Ͻ5 m thoracic, and lumbar spinal cord were screened. Secin diameter) axons (SCAs) and large caliber (Ͼ5 m in tions of brain showed limited expression of dynamitin diameter) axons (LCAs) in 4-to 7-month-old presympin transgenic mice and no unusual staining of neurofilatomatic, 10-to 14-month-old early symptomatic, ments or synaptophysin (data not shown). Spinal cord and Ͼ16-month-old late symptomatic mice to determine motor neurons in the ventral horn of early symptomatic if one population of axons was selectively vulnerable to transgenic mice stained intensely for dynamitin (Figures the effects of transgene expression. 4-to 7-month-old 5D, 5J, and 5P), but not in age-matched controls ( Figures  5A, 5G, and 5M) . It should be noted that even though presymptomatic transgenic mice have no significant dif- ferences in the number of the SCAs (98% Ϯ 3%) and In the Ͼ16-month-old late symptomatic transgenic mice ( Figure 6F ), evidence of degeneration and axonal LCAs (101% Ϯ 1%) when compared to wild-type mice in the same age group. Ten-to fourteen-month-old early loss is seen when compared to wild-type mice of the same age group ( Figure 6E ). There are degenerate axsymptomatic transgenic mice have 96% Ϯ 4% of the SCAs and 90% Ϯ 4% of the LCAs of wild-type mice in ons, axonal inclusions, myelin defects, and an increase in space between axons, suggesting axonal loss (Figure the same age group. A significant decrease (t test, p Ͻ 0.02) was found in the number of LCAs of Ͼ16-month-6F). These observations are similar to those described in EM analysis of ventral roots in mutant SOD-1 mice old late symptomatic transgenic mice when compared to Ͼ16-month-old wild-type mice. Late symptomatic (Bruijin et al., 1997). We also observed many axons with involutions or invaginations of the myelin sheath into transgenic mice have 99% Ϯ 2% of SCAs but only 65% Ϯ 2% of the LCAs found in Ͼ16-month-old wildthe axons, indicating axonal atrophy and suggesting a deficient or collapsed cytoskeleton. type mice.
No abnormalities or significant differences are found in L5 ventral roots of 4-to 7-month-old presymptomatic Delay in Retrograde Transport Observed in Early Symptomatic Transgenic Mice transgenic mice ( Figure 6B ) when compared to wildtype mice ( Figure 6A ). In the 10-to 14-month-old early In order to directly correlate the degenerate changes seen in motor neurons and their axons and the developsymptomatic transgenic mice (Figure 6D ), an upward trend in the variability of axonal caliber is noted with no ment of the observed phenotype in transgenic mice with disruptions in axonal transport, neurotracer studies significant loss of axonal numbers when compared to wild-type mice in the same age group as described were performed. Transgenic mice and age-matched wild-type controls were injected with the retrograde above ( Figure 6C ). This loss of axonal caliber size maintenance may be due to deficiencies in the slow transport neurotracer fluoro-gold in the gastrocnemius muscle and sacrificed at 44 and 46 hr to determine the number of neurofilaments. of motor neuron cell bodies that had accumulated fluAccumulation of the fluoro-gold neurotracer was observed in whole motor neuron pools that innervate the oro-gold (Schmued, 1994) . No significant differences were detected in presymptomatic mice. Retrograde injected muscle at the 44 and 46 hr time points in wildtype mice and is demonstrated in Figure 7B . In contrast, transport could not be quantitated in late symptomatic transgenic mice because of the significant loss of motor transgenic mice in the same age group had only an occasional cell with fluoro-gold accumulation at the 44 neurons found in this group. Therefore quantitation of transport deficits was performed on 10-to 14-monthand 46 hr time points (Figure 7A ), while still possessing normal motor neuron numbers in this age group of mice old early symptomatic transgenic mice in comparison to wild-type controls.
(H&E results and Figure 7A , inset). These rare labeled cells may correspond to motor neurons that do not overSciatic nerve ligations of symptomatic transgenic express dynamitin, as high levels of dynamitin were obmice and age-matched controls were also performed to served in only a subset of motor neurons ( Figure 5) . probe for possible differences in anterograde transport. At 44 hr, the average number of labeled cells per However, over a 2-6 hr time course, no consistent, apmouse is 46.5 Ϯ 16.5 (average Ϯ SE; n ϭ 6) in wild-type preciable difference could be found between transgenic mice, whereas the average number of labeled cells per and wild-type mice. Given the relatively short time frame mouse is 15.2 Ϯ 8.5 (n ϭ 4) in early symptomatic 10-of this experiment and the limited overexpression of to 14-month-old transgenic mice (p ϭ 0.135). At 46 hr dynamitin to motor neurons within a mixed cell populapostinjection of fluoro-gold, a significant decrease of tion in the sciatic nerve, definitive conclusions cannot labeled cells was found in transgenic mice ( Figure 7A) be drawn about the possible effects of dynamitin overwhen compared to the accumulation observed in wildexpression on anterograde axonal transport. The signifitype mice ( Figure 7B ). An average of 48.7 Ϯ 7.4 (n ϭ 6) cant inhibition of retrograde rather than anterograde labeled cells per wild-type mouse was found, whereas transport in the transgenic mice is consistent with dynan average of only 16.0 Ϯ 5.8 labeled cells per mouse ein's role as a minus-end-directed microtubule motor. was found in early symptomatic transgenic mice (t test, p Ͻ 0.01) (Figure 7C lated to initiate degeneration of motor neurons, which
